drug
sodium nitrite
Marketedupdated 3mo agoby Hope Biosciences LLC
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for myocardial infarction and poisoning and 17 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying sodium nitrite
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 10, 2030
~3.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Dec 24, 2031compositionUS 8568793
- Feb 10, 2030formulationUS 96875063.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that